Senthil Vel Sundaram - 31 May 2023 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role
Chief Executive Officer, Director
Signature
/s/ Bryan Yoon, as Attorney-in-Fact for Senthil Sundaram
Issuer symbol
TERN
Transactions as of
31 May 2023
Net transactions value
+$2,977
Form type
4
Filing time
02 Jun 2023, 17:03:03 UTC
Previous filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TERN Common Stock Purchase $2,977 +2,111 +28% $1.41* 9,770 31 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes the purchase of 2,111 shares under the Terns Employee Stock Purchase Plan on May 31, 2023.

Remarks:

Voluntary reporting of ESPP purchase